Vivos Inc. Email Format

Biotechnology ResearchWashington, United States2-10 Employees

Vivos Inc. is a biotechnology company focused on targeted brachytherapy for cancer, employing a yttrium-90 based injectable device. Its offerings include IsoPet for treating tumors in animals and RadioGel for human use, both built on a hydrogel platform that places radiation directly within the tumor. This internal delivery minimizes the skin dose and some side effects associated with external radiotherapy, enabling higher radiation doses for tumors that are difficult to resect or resistant to conventional treatment. 

Regulatory context supports its veterinary strategy: in 2018, the FDA Center for Veterinary Medicine affirmed IsoPet as a medical device for its intended use, with canine and feline sarcomas among the initial indications and no pre-market approval required for veterinary devices. IsoPet and RadioGel share the same underlying technology but carry different product names to avoid confusion, and IsoPet is marketed to university animal hospitals and private veterinary clinics. The company is based in Richland, Washington, and operates as a small biotechnology research enterprise.

Sign up for free to view info

Company overview Employee directory